Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+cells into mouse skin

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 5, 2011, Pages 354-362

  Matsui, K ^a   Nishikawa, A ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; CCL17; CCR4; Peptidoglycan; Staphylococcus aureus

Indexed keywords

CHEMOKINE RECEPTOR CCR4; HOUSE DUST ALLERGEN; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; PEPTIDOGLYCAN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; CELL INFILTRATION; CONTROLLED STUDY; DERMIS; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IN VITRO STUDY; KERATINOCYTE; LANGERHANS CELL; MOUSE; NONHUMAN; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN SENSITIZATION; STAPHYLOCOCCUS AUREUS; TH2 CELL;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL17; CHEMOKINE CCL22; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HUMANS; IMMUNIZATION; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; PEPTIDOGLYCAN; PYROGLYPHIDAE; RECEPTORS, CCR4; SKIN; STAPHYLOCOCCUS AUREUS; TH2 CELLS; UP-REGULATION;

EID: 80051771038     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol. 1995;96:302-19.
2. Gloor M, Peters G, Stoika D. On the resident aerobic bacterial skin fl ora in unaffected skin of patients with atopic dermatitis and in normal controls. Dermatologia. 1992;164:258-65.
3. Matsui K, Nishikawa A, Suto H, Tsuboi R, Ogawa H. Comparative study of Staphylococcus aureus isolated from lesional and nonlesional skin of atopic dermatitis patients. Microbiol Immunol. 2000;44:945-7.
4. Lambert PA, Hancock IC, Baddiley J. Occurrence and function of membrane teichoic acids. Biochim Biophys Acta. 1977;472:1-12.
5. Fischer W. Bacterial phosphoglycolipids and lipoteichoic acids. In: Hannah DJ, editor. Handbook of lipid research. New York: Plenum; 1989. p. 123-234.
6. Matsui K, Motohashi R, Nishikawa A. Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis. J Interferon Cytokine Res. 2000;20:321-4.
7. Matsui K, Nishikawa A. Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with an allergen. Clin Exp Allergy. 2002;32:783-8.
8. Matsui K, Nishikawa A. Percutaneous application of peptidoglycan from Staphylococcus aureus induces an increase in mast cell numbers in the dermis of mice. Clin Exp Allergy. 2005;35:382-7.
9. Matsui K, Wirotesangthong M, Nishikawa A. Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin. Clin Exp Allergy. 2007;37:615-22.
10. Tada Y, Asahina A, Nakamura K, Tomura M, Fujiwara H, Tamaki K. Granulocyte/macrophage colony-stimulating factor inhibits IL-12 production of mouse Langerhans cells. J Immunol. 2000;164:5113-9.
11. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem. 1999;274:17406-9.
12. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2. J Immunol. 1999;163:1-5.
13. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA. 2000;97:13766-71.
14. Taskapan MO, Kumar P. Role of staphylococcal superantigens in atopic dermatitis: from colonization to infl ammation. Ann Allergy Asthma Immunol. 2000;84:3-12.
15. Jappe U, Heuck D, Witte W, Gollnick H. Superantigen production by Staphylococcus aureus in atopic dermatitis: No more than a coincidence? J Invest Dermatol. 1998;110:844-6.
16. Zollner TM, Wichelhaus TA, Hartung A, Von Mallinckrodt C, Wagner TOF, Brade V, Kaufmann R. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy. 2000;30:994-1000.
17. Imai T, Baba M, Nishimura M, Kakizaki M, Takagi S, Yoshie O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem. 1997;272:15036-42.
18. Imai T, Chantry D, Raport C, Wood C, Nishimura M, Godiska R, Yosie O, Gray P. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem. 1998;273:1764-8.
19. Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, Yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999;11:81-8.
20. Uchida T, Suto H, Ra C, Ogawa H, Kobata T, Okumura K. Preferential expression of Th2-type chemokine and its receptor in atopic dermatitis. Int Immunol. 2002;14:1431-8.
21. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T, Harada S, Fukunaga A, Chantry D, Gray PW, Morita A, Suzuki R, Tezuka T, Ichihashi M, Yoshie O. IFN-ã-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol. 2002;14:767-73.
22. Nakazato J, Kishida M, Kuroiwa R, Fujiwara J, Shimoda M, Shinomiya N. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis. Pediatr Allergy Immunol. 2008;19:605-13.
23. Leung DYM, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest. 2004;113:651-7.
24. Re F, Strominger JL. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem. 2001;276:37692-9.
25. Tsuda T, Tohyama M, Yamasaki K, Shirakata Y, Yahata Y, Tokumaru S, Sayama K, Hashimoto K. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci. 2003;31:37-42.
26. Xiao T, Fujita H, Saeki H, Mitsui H, Sugaya M, Tada Y, Kakinuma T, Torii H, Nakamura K, Asahina A, Tamaki K. Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-〈 and IL-4 and downregulated by IFN-γ. Cytokine. 2003;23:126-32.
27. Elentner A, Finke D, Schmuth M, Chappaz S, Ebner S, Malissen B, Kissenpfennig A, Romani N, Dubrac S. Langerhans cells are critical in the development of atopic dermatitis-like infl ammation and symptoms in mice. J Cell Mol Med. 2009;13:2658-72.
28. Chen H, Centola M, Altschul S, Metzger H. Characterization of gene expression in resting and activated mast cells. J Exp Med. 1998;188:1657-68.
29. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol. 1991;96:523-6.